Peptides are a group of biologically active substances that are involved in various cellular functions of organisms.Peptides are frequently utilized in functional analysis, research on vaccines, and particularly in the production of pharmaceuticals. More than 80 peptide medications are already available on the market to treat a variety of illnesses, such as diabetes, cancer, osteoporosis, multiple sclerosis, HIV infection, and chronic pain.
Structure | Cat No. | Product Name | CAS No. | Product Description |
---|---|---|---|---|
![]() |
V36932 | p60 v-src (137-157) | 131023-24-0 | P60v-src(137-157) is a synthetic peptide that can inhibit the tyrosine kinase activity of p60v-src (IC50= 7.5 μM). |
![]() |
V35539 | P60c-src Substrate II | 16875-27-7 | H-Thr-Phe-OH is a bioactive peptide discovered by peptide screening. |
![]() |
V36636 | PACAP-27 (6-27) (human, chicken, mouse, ovine, porcine, rat) | 136134-68-4 | PACAP (6-27) (human, ovine, rat) is a PACAP receptor blocker (antagonist) that blocks the canine adrenal catecholamine response to exogenous vasoactive intestinal peptide (VIP). |
![]() |
V36639 | PACAP-38 (28-38) (human, chicken, mouse, ovine, porcine, rat) | 160489-86-1 | PACAP-38 (28-38) (human, chicken, mouse, ovine, porcine, rat) is a bioactive peptide discovered by peptide screening. |
![]() |
V36637 | PACAP-38 (human, mouse, ovine, porcine, rat) | 124123-15-5 | PACAP-38 (human, mouse, ovine, porcine, rat) is a peptide compound. |
![]() |
V36635 | PACAP Related Peptide (1-29) (rat) | 132769-35-8 | PACAP Related Peptide (1-29) (rat) is a peptide compound. |
![]() |
V35614 | Pancreastatin: 37-52,human | 133605-57-9 | Pancreastatin (37-52), human is a pancreastatin fragment. |
![]() |
V35615 | PAR-2 (1-6) (mouse,rat) | 164081-25-8 | PAR-2 (1-6) (mouse,rat) is a peptide compound. |
![]() |
V35616 | PAR-4 (1-6) (mouse) | 213018-42-9 | PAR-4 (1-6) (mouse) is a peptide compound. |
![]() |
V36216 | Pbf-Cl | Pbf-NH2 is a peptide compound. | |
![]() |
V35617 | PDGF Antagonist | 143784-00-3 | PDGF Antagonist is a peptide compound. |
![]() |
V36997 | Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge:D-Cys2-Cys8) | 429619-37-4 | Phe(4-Cl)-D-Cys-β-(2-pyridyl)-Ala-Trp-Lys-Val-Cys-2-Nal-NH2(Disulfidebridge:D-Cys2-Cys8) is a peptide compound. |
![]() |
V37067 | PHI-27 (rat) | 96849-38-6 | PHI-27 (rat) is a 27 amino acid (AA) peptide. |
![]() |
V37068 | PHM-27 (human) | 87403-73-4 | PHM-27 (human) is a human pro-vasoactive intestinal polypeptide (27 amino acid (AA)s). |
![]() |
V36935 | PKI-tide | 126370-52-3 | The IC50 of PKItide for cAMP-PK is 0.2 μM. |
![]() |
V36936 | pp60 c-src (521-533) | 198754-34-6 | pp60 c-src (521-533) is a peptide compound. |
![]() |
V36937 | pp60 c-src (521-533) (phosphorylated) | 149299-77-4 | pp60 c-src (521-533) (phosphorylated) is the peptide corresponding to the carboxyl-terminal regulatory domain of pp60c-src, and is phosphorylated at Tyr527. |
![]() |
V37069 | Prepro VIP (156-170) (human) | 107902-86-3 | Prepro VIP (156-170) (human) is a peptide compound. |
![]() |
V35618 | Prepro-Atrial Natriuretic Factor (26-55) (human) | 112160-82-4 | Prepro-Atrial Natriuretic Factor (26-55) (human) is a bioactive peptide that increases circulating GMP levels in the renal cortex and medulla. |
![]() |
V35619 | Prepro-Atrial Natriuretic Factor (56-92) (human) | 112199-06-1 | Prepro-ANF (56-92), human is a human atrial natriuretic factor precursor. |